CC
Callan Capital Portfolio holdings
AUM
$1.35B
This Quarter Return
+10.18%
1 Year Return
+8.35%
3 Year Return
+20.11%
5 Year Return
+98.58%
10 Year Return
+94.69%
AUM
$810M
AUM Growth
+$810M
(+32%)
Cap. Flow
+$133M
Cap. Flow
% of AUM
16.45%
Top 10 Holdings %
Top 10 Hldgs %
49.65%
Holding
195
New
66
Increased
84
Reduced
25
Closed
9
Top Buys
Top Sells
Sector Composition
| 1 | Technology | 3.22% |
| 2 | Healthcare | 1.73% |
| 3 | Financials | 1.6% |
| 4 | Real Estate | 0.78% |
| 5 | Communication Services | 0.61% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
126
ASML
ASML
$288B
| $358K | 0.04% |
655
+4
| +0.6% | +$2.19K |
|
127
Texas Instruments
TXN
$176B
| $347K | 0.04% |
2,099
| – | – |
|
128
Wells Fargo
WFC
$259B
| $346K | 0.04% |
+8,384
| New | +$346K |
|
129
Illinois Tool Works
ITW
$76.1B
| $345K | 0.04% |
+1,568
| New | +$345K |
|
130
iShares MSCI KLD 400 Social ETF
DSI
$4.8B
| $344K | 0.04% |
4,798
| – | – |
|
131
Verizon
VZ
$183B
| $344K | 0.04% |
+8,742
| New | +$344K |
|
132
Schwab US REIT ETF
SCHH
$8.25B
| $344K | 0.04% |
17,830
+536
| +3% | +$10.3K |
|
|
PSTX
133
DELISTED
Poseida Therapeutics, Inc. Common Stock
PSTX
| $330K | 0.04% |
+62,347
| New | +$330K |
|
134
T-Mobile US
TMUS
$284B
| $326K | 0.04% |
2,327
| – | – |
|
135
Intel
INTC
$105B
| $324K | 0.04% |
12,273
+178
| +1% | +$4.7K |
|
136
Abbott
ABT
$228B
| $324K | 0.04% |
+2,950
| New | +$324K |
|
137
AES
AES
$9.41B
| $323K | 0.04% |
11,216
| – | – |
|
138
Broadcom
AVGO
$1.42T
| $322K | 0.04% |
576
+27
| +5% | +$15.1K |
|
139
iShares MSCI EAFE Min Vol Factor ETF
EFAV
$5.37B
| $320K | 0.04% |
+5,039
| New | +$320K |
|
140
Nike
NKE
$110B
| $315K | 0.04% |
+2,693
| New | +$315K |
|
141
Trane Technologies
TT
$90.5B
| $315K | 0.04% |
+1,874
| New | +$315K |
|
142
WEC Energy
WEC
$34.3B
| $304K | 0.04% |
+3,246
| New | +$304K |
|
143
Vertex Pharmaceuticals
VRTX
$101B
| $302K | 0.04% |
+1,045
| New | +$302K |
|
144
AT&T
T
$207B
| $298K | 0.04% |
+16,169
| New | +$298K |
|
145
Eli Lilly
LLY
$659B
| $297K | 0.04% |
+812
| New | +$297K |
|
146
Uber
UBER
$196B
| $296K | 0.04% |
+11,953
| New | +$296K |
|
147
S&P Global
SPGI
$165B
| $293K | 0.04% |
+874
| New | +$293K |
|
148
iShares Core MSCI Emerging Markets ETF
IEMG
$102B
| $288K | 0.04% |
6,174
-2,364
| -28% | -$110K |
|
149
Novo Nordisk
NVO
$253B
| $287K | 0.04% |
2,122
+100
| +5% | +$13.5K |
|
150
Chevron
CVX
$319B
| $280K | 0.03% |
+1,562
| New | +$280K |
|